As the first phase of a two-phase prospective cohort study to assess the acceptability of the diaphragm as a potential HIV/STI prevention method, we conducted a 2-month prospective study and examined the effect of a male and female condom intervention on female condom (FC) use among 379 sexually active women in Harare, Zimbabwe. Reported use of FC increased from 1.1% at baseline to 70.6% at 2-month follow-up. Predictors of FC uptake immediately following the intervention included interest in using FC, liking FC better than male condoms, and believing one could use them more consistently than male condoms. Women reported 28.8% of sex acts protected by FC in the 2 weeks prior to last study visit. Though FC may not be the preferred method for the majority of women, with access, proper education, and promotion they may be a valuable option for some Zimbabwean women.
The Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates that more than 33 million people are infected with HIV. Women are more vulnerable to HIV infection for both biological and cultural reasons (Susser & Stein, 2000) . New survey data released by UNAIDS shows that in sub-Saharan Africa, women are disproportionately infected by HIV at a 3:2 ratio, on average. Zimbabwe is one of the countries worst affected by the epidemic, with an HIV prevalence rate of 20.1% among 15-to-49-year-olds (UNAIDS, 2006) .
Twenty years into the HIV epidemic, female condoms are the only currently available female-initiated method of HIV and sexually transmitted infection (STI) prevention (Bull, Posner, Ortiz, & Evans, 2003; FHI Research Briefs) . Female condoms became commercially available 13 years ago and are now marketed in over 90 developing countries (Hoffman, Mantell, Exner, & Stein, 2004) . There have been both successes and disappointments in the uptake of this method around the globe. However, continued promotion of this method is important, as currently it is the only barrier alternative to male condoms and can provide women with increased control in reproductive health decision making.
Incident pregnancy rate within the first year is approximately 5% for perfect use, as compared to 3% for the male condom, and 21% for typical use as compared to 15% for the male condom (Hatcher et al., 1998; Trussell & Kowal, 1998) . There are no studies to date that examine the effectiveness of the female condom in preventing HIV acquisition in humans; however, the female condom is impermeable to HIV, cytomegalovirus, hepatitis B virus, and herpes simplex virus (Drew, Blair, Miner, & Conant, 1990; Voeller, Coulter, & Mayhan, 1991) . Studies examining effectiveness against STIs are few. Three randomized controlled trials for STI prevention have been conducted: two were designed as effectiveness trials (Feldblum et al., 2001; Fontanet et al. 1998 ) and one was a noninferiority trial to demonstrate effectiveness compared to male condoms (French, Latka, Gollub, Rogers, Hoover, & Stein, 2003) . All three showed no difference between arms. In addition, there is evidence that the availability of the female condom, in addition to male condoms, may contribute to an overall higher proportion of protected sex acts (Fontanet et al., 1998) .
Worldwide, acceptability of the female condom is variable with ranges from 37% to 96% depending on settings and populations (World Health Organization, 1997) . Of the few studies that have examined female condom use over 6 months or more, all but one showed an increase in proportion of protected sex acts overall with promotion and provision of female condoms. A study among STI clinic attendees in Alabama, showed that over a 6-month period the rate of protected sex acts increased from 40% to 50% of sex acts with introduction of the female condom (Artz et al., 2000) . Use of male condoms did not decrease, and most women who used the female condom used male condoms as well. A study of female condom acceptability among high-risk couples in Zambia found that approximately 25% of all coital acts were protected by the female condom over a 1-year period. Additionally results suggested that the number of protected acts overall increased with the introduction of the female condom (Musaba, Morrison, Sunkutu, Musonda, & Wong, 1998) .
In the mid-1990s, an acceptability study done in Zimbabwe showed a high demand for the female condom, and subsequently Zimbabwean women petitioned the government to make female condoms widely available (Warren & Philpott, 2003) . In 1996 the female condom was approved for use in Zimbabwe, and in 1997 Population Services International (PSI) began a social marketing campaign in which female condoms were subsidized and distributed in urban areas (Warren & Philpott, 2003) . These condoms were marketed as a method of contraception to avoid the stigma of STI prevention that male condoms had in Zimbabwe (Meekers & Richter, 2005; Warren & Philpott, 2003) . One study among people who purchased the female condom at retail outlets in urban Zimbabwe demonstrated that factors associated with use included perceived ease of use and affordability, as well as ever having used the male condom (Meekers & Richter, 2005) . In parallel, the Ministry of Health launched a distribution program targeted toward rural areas. Distribution of the female condom escalated from approximately 300,000 condoms sold in 1998 to over 1.6 million in 2002 (Warren & Philpott, 2003) .
We previously reported on diaphragm acceptability and mixed-method use of male condoms, female condoms, and the diaphragm, among a sample of sexually active women who were inconsistent condom users following a 2-month condom intervention study, in Harare, Zimbabwe Buck et al., 2005; Kang et al., 2006 Van der Straten, Kang, Posner, Kamba, Chipato, & Padian, 2005 . Here we report the effect of a 2-month male and female condom intervention on female condom acceptability and use among sexually active women who, at study entry, reported using condoms inconsistently, in Harare, Zimbabwe. Results of this study provide additional support that the female condom is acceptable to some at-risk women.
METHODS

STUDY DESIGN AND POPULATION
A two-phase prospective cohort study to assess the acceptability of the diaphragm as a potential HIV/STI prevention method was conducted, and results of the first phase are reported here. The purpose of the first phase was to identify women who, after a brief intervention, could not use condoms consistently so that they would then be enrolled in the diaphragm study (phase 2). After reviewing the data on FC acceptability and uptake in phase 1, it was deemed important for publication. Women were recruited from reproductive health and family planning clinics in Harare, Zimbabwe, between December 2000 and December 2001. To participate in the study, women had to be between 16 and 48 years old, healthy, not pregnant, and not wanting to become pregnant for the next 8 months. They were required to be sexually active (at least 10 acts of sex in the past 2 months), have no allergy to latex, and report condom use less than 100% of the time. Women were recruited irrespective of HIV serostatus; however, free HIV counseling and testing was offered as a service. Eligible women provided written consent and were enrolled into the condom intervention study.
STUDY VISITS AND PROCEDURES
The condom intervention study consisted of three visits over a period of 2 months. The first (baseline) visit took place immediately following enrollment. At the first visit a detailed questionnaire was administered by a trained interviewer. Following the questionnaire, participants had a pelvic examination, urine collection for pregnancy testing, and STI syndromic diagnosis and treatment. Free HIV ELISA testing and counseling by a trained provider was offered as a benefit of study participation. Women found to be HIV-positive were allowed to remain in the study and were also referred for additional support services.
MALE AND FEMALE CONDOM INTERVENTION
Following the baseline interview, women participated in a 30-minute one-on-one counseling program about HIV and safer sex conducted by a trained counselor. Immediately after the intervention, participants received an educational assessment interview, to document what they had learned from the intervention. A hierarchical counseling message was used, presenting the male condom as the most effective method for prevention of HIV/STIs, followed by the female condom whose effectiveness is less well known. The condom intervention was based on social-cognitive models of behavior change. It emphasized enhancing condom self-efficacy and negotiation skills and included education about HIV and STI transmission, HIV/STI risk assessment, safer sex options, and demonstration and practice of proper use of male and female condoms. For the female condom, after demonstration by the staff, participants practiced opening the female condom packet and inserting it into a pelvic model until they were comfortable with the procedure. Problem solving around individually identified relationship and practical barriers to use was conducted and partic-ipants had opportunities to role-play condom negotiation with the counselor. After the counseling session, participants practiced inserting the female condoms on themselves, aided by the study clinician. Participants were given a 1-month supply of both male and female condoms and were encouraged to drop in any time if additional condoms were needed.
FOLLOW-UP VISITS
Participants had two monthly follow-up visits. Participants were resupplied with male and female condoms at each visit. At the 1-month follow-up visit, they received a booster counseling session on condom use, with content similar to enrollment. At the 2-month follow-up visit, participants completed a pictorial self-administered retrospective coital calendar covering 2 weeks prior to the study visit, and received an interviewer-administered follow-up interview. Participants then had a final pelvic examination, urine collection for pregnancy testing, and STI syndromic diagnosis and treatment.
MEASURES
At baseline women were given an interview-administered questionnaire. The questionnaire included questions about demographics, medical history, sexual history and behavior, vaginal practices, opinions about contraceptive methods, drug use, and domestic violence. Women were also asked if they had used the female condom for pregnancy prevention (yes/no) and for HIV/STI prevention (yes/no) (a) ever, (b) in the past 2 months, and (c) now. We determined use for both pregnancy and HIV/STI prevention by looking at the intersection of these two questions. Women were asked to identify all methods of contraception they currently used (defined as using "now") at baseline from an array of listed methods (tubal ligation, birth control pills, IUD, male condoms, female condoms, spermicides, diaphragm, Norplant, Depo Provera, partner vasectomy, rhythm, douching, withdrawal, traditional, other). From this, indicator variables were created for those using both hormonal or permanent, and barrier methods, those using only a hormonal or permanent method, those using only a barrier method and those not using any of the above-mentioned methods. Women were asked which method they liked best (and least) for pregnancy prevention and HIV/STI prevention from those they had ever used. Baseline male partner variables were assessed, including whether the partner worked, how often he was under the influence of alcohol or drugs during sex in the past 6 months (four response categories: every time, about half the time, occasionally, never), and if there was a history of domestic violence.
The educational assessment interview was administered immediately following the initial condom promotion and counseling session and asked about perceived effectiveness of the female condom for pregnancy and HIV/STI prevention, how interested women were in using the female condom (three response categories: not at all interested, somewhat/moderately interested, very/extremely interested), which method between the male and female condom they liked better, and which they thought they could use more consistently. Women were also asked to assess the perceived effectiveness of the female condom for pregnancy and HIV/STI prevention (three response categories: not at all effective, somewhat/moderately effective, very/extremely effective), and these two questions were asked again at the end of the 2-month follow-up, during the final interview-administered questionnaire.
At the end of the 2-month follow-up period women were given a second interviewer-administered questionnaire. Again women were asked if they had used the female condom for pregnancy prevention (yes/no) and for HIV/STI prevention (yes/no) (a) in the previous 2 months (since last questionnaire) and (2) whether they used it now. Uptake of the female condom, was defined as "current" use (i.e., use "now"). Again, women were asked which method they liked best (and least) for pregnancy prevention and HIV/STI prevention from the listed methods they had used in the past 2 months.
The self-administered questionnaire (SAQ) was in the form of a coital calendar. Women put stickers on the calendar indicating which day(s) they had sex and what methods, if any, were used in the previous 2 weeks. At the 2-month visit, we used this SAQ to determine the proportion of sex acts protected by the female condom in the previous two weeks, and to identify women reporting 100% female condom use in the previous 2 weeks.
STATISTICAL METHODS AND DATA ANALYSIS
Preference and use data are presented for the women who completed the 2-month condom intervention study. Bivariate associations with reported female condom use and preference were tested using Student's t, chi-square, and Fisher's exact tests. Exploratory analyses of the association between reported female condom use at study exit, baseline demographics, behavioral and attitudinal factors were based on bivariate comparisons using chi-square and Fisher's exact statistics to assess significance of observed associations. An alpha level of .05 was used to judge the statistical significance of each effect. Because only a few factors were associated with the outcomes and because these factors were highly correlated, logistic regression results are presented as adjusted odds ratios for individual factors controlling for age (an a priori decision was made to include age in all models). In bivariate and logistic models the attitudes data included are from the post intervention assessment. We chose to include this because it more accurately reflected attitudes prior to use. Data were analyzed using SAS software, Version 9.1.
RESULTS
We screened 842 women: 424 were eligible, and of those 405 (95%) were enrolled into the condom intervention study. Three hundred seventy nine (94% of those enrolled) completed the 2 months of follow-up and constitute the analytical sample for this article.
As shown in Table 1 , the average age of participants was 28 (range: 16-48), 97.4% were married, and 69.1% had one lifetime sexual partner. The mean number of children was 2.5 (range: 0-10), and 51.7% had finished at least secondary education. Of the 303 women who elected to take an HIV test at baseline, 75 were HIV-positive. Most women were using hormonal contraception. Of the 41 who reported barrier method use, all were using male condoms, and four were also using female condoms.
Perceived effectiveness of the female condom in preventing pregnancy and HIV/STIs was high at baseline and did not change postintervention. Preintervention, 74.7% (n = 283) of women reported that the female condom was very/extremely effective in preventing pregnancy, and 68.3% (n = 259) reported it was very/extremely effective in preventing HIV/STIs. Postintervention, this changed to 72.0% and 70.1%, respectively (see Table 2 ). Interest in using the female condom for pregnancy or HIV/STI prevention was high with 75.9% of women postintervention reporting they were very/extremely interested and 35.6% thought they could use the female condom more consistently than male condoms. At baseline, as Table 2 shows, only 21 women (5.5%) had reported ever using a female condom, and eight reported using them in the previous 2 months (one woman reported using it for pregnancy prevention only, five women for prevention of STI/HIV only, and two for both). At the 2-month visit, of the 337 women who reported female condom use in the past 2 months, the large majority (89%, n = 300) reported using it for both pregnancy and HIV/STI prevention. Reported current use of FC (use "now") increased from 1.1% (n = 4) at baseline to 70.6% (n = 266) at the end of the study.
As reported on the SAQ at study end, of the 373 women who had sex in the previous 2 weeks, 68.1% had used the female condom at least once, corresponding to 28.8% of recent sex acts having been protected by the female condom. Twenty women (5.4%) reported using the female condom as their only barrier method in the previous 2 weeks. Of the 240 women who reported 100% of sex acts protected by a barrier method in the past 2 weeks, 67.5% used the FC for at least a portion of their sex acts and 8.3% reported using only the FC to protect all sex acts.
We examined associations with female condom uptake (defined as current use at the 2-month-2 visit) using the following baseline predictors: sociodemographics; ever having used the female condom; contraceptive use; and variables collected during the postcounseling educational assessment, including interest in using the female condom, preferring the female condom to the male condoms, thinking they could use the female condom more consistently than male condoms, and perceived effectiveness of female condoms. We also examined baseline partner factors, including whether the partner worked, was under the influence of alcohol or drugs during sex, and whether there was a history of domestic violence. Finally, we looked at HIV status at entry into the study. As shown in Table 3 , in bivariate analysis as well as logistic regression, in- Note. †2 women used for both pregnancy and HIV/STI prevention. ‡300 women used for both pregnancy and HIV/STI prevention. *Denominator is 373, women who had sex in the past 2 weeks. , and thinking the female condom can be used more consistently than male condoms (AOR: 2.20, CI: 1.34-3.62) were significantly associated with female condom uptake. Perceived effectiveness against either pregnancy or HIV/STIs was not significantly associated with female condom uptake (AOR: 1.52, CI: 0.90-2.57). Sociodemographic factors, partner factors and HIV status showed no association with the outcome variable. Although the number of women was small (n = 20), we analyzed factors associated with reporting 100% female condom use in the past two weeks at 2-month. Liking female condoms better than male condoms (AOR: 16.4, CI: 3.7 -71.8, p = 0.00), and thinking they can use the female condom more consistently than male condoms (AOR: 18.5, CI: 4.2 -81.4, p = ..00) were associated with 100% use in logistic regression.
Women were asked to select their preferred method for pregnancy and disease prevention from among those they had ever used. At baseline, birth control pills were most often listed as the preferred method for pregnancy prevention (35%), and only one woman (0.1%) stated that the female condom was her preferred method. In contrast, at the 2-month visit, male condoms were most often listed as their preferred method for pregnancy prevention (47%). Furthermore, at the 2-month visit, 20% (76) of women liked the female condom best for pregnancy prevention, 25% (96) for STI/HIV prevention, for a total of 27% (102) for either pregnancy or HIV prevention. Of those who liked the female condom best at 2-month follow-up, 99% were using the female condom in the past 2 weeks and 13% had used the female condom for 100% of sex acts in the past 2 weeks. Women were also asked to select from the method they had used, the one they liked the least. Of the 234 women who selected the FC as their least liked method for disease prevention at the 2-month visit, the two most common responses were that it was "uncomfortable" (38.0% ) and that it was not dependable (31.9%). These were the same two chief complaints given by the 194 women who selected the FC as their least liked method for contraception.
We examined factors associated with liking the female condom best at Month 2 for either pregnancy or disease prevention (Table 4) . Controlling for age, in logistic regression, belief in the effectiveness of female condoms (AOR: 3.00, C: 1.48-6.1), interest in using female condoms (AOR: 2.43, C: 1.31-4.54), liking female condoms better than male condoms (AOR: 5.97, , and believing that they could use them more consistently than male condoms (AOR: 4.41, CI: 2.73-7.15) were all predictors of liking the female condom best for pregnancy or HIV/STI prevention.
DISCUSSION
Despite a social marketing campaign beginning in the mid-1990's promoting the female condom in Zimbabwe, uptake of this method has been relatively minimal. Though records show a steady increase of the female condom sales from 1998 to 2002, in our study sample in Harare, Zimbabwe, only a small percentage of women had ever used this method. However, prior to the intervention, perceived effectiveness of the female condom was high, and following education and counseling, reported use of the female condom greatly increased over a 2-month period. The best predictors of female condom uptake were measures taken after the counseling intervention, rather than baseline measures. Furthermore, liking female condoms best for HIV/STI or pregnancy prevention greatly increased over the 2-month follow-up as well. Interest in the female condom, preference over male condoms and believing they can be used more consistently than male condoms were significantly associated with female condom uptake at 2-month follow-up. Perceived effectiveness of the female condom did not change with the intervention, though it was associated with liking this method best, and the large majority of women reported using the female condom for the dual purpose of pregnancy and disease prevention. A small percentage of women (5.4%) reported using the female condom exclusively at the 2-month follow-up.
One limitation of this study is that we did not assess the long-term use and acceptability of the female condom. Factors associated with initial uptake may be different from those associated with long-term use (Artz et al., 2000; Musaba et al.,1998) . Other studies have shown that although not all women will show a continued interest in female condom use, for a percentage of women the female condom will be preferred, thereby filling an important niche (Cecil, Perry, Seal, & Pinkerton, 1998; Hart et al., 1999; Hoffman, Exner, Leu, Ehrhardt, & Stein, 2003; Ray et al. 1998; Yimin et al. 2002) . Also noteworthy is that most women (>90%) when they entered the study were already using hormonal contraception, so there may have been less incentive to use the female condom than for women who decide to use it as their primary contraceptive method. Thus, findings from this study may not be generalizable to noncontracepting women or to those who may decide to use female condoms as their primary contraceptive method.
Few women were exclusive users of the female condoms, and many used mixed methods. Those who were not 100% condom users continued into the second phase of the study, looking at barrier method preferences among women and men in Zimbabwe. Among the three methods evaluated-male condoms, female condoms, and the diaphragm-it was found that though female condoms were used least frequently, the majority of women did use a mix of all three methods (Buck et al. 2005; Posner et al. 2005) . This may indicate that increasing the number of available options/choice for these women may increase their ability to protect themselves. Furthermore, there seems to be a small, although important, group of women who may want to use female condoms exclusively, for whom increased access maybe important.
In this analysis of female condom use, many women seem to have a favorable perception of female condom effectiveness at baseline, and with a brief intervention, attitude and use was easily enhanced. We hypothesize that one of the major limitations to female condom use in Zimbabwe is access and education on proper use, and for program planners, if this is enhanced, use will increase. Additionally, almost all women reported using the female condom for the dual purpose of pregnancy and HIV/STI prevention. The female condom is currently promoted as a contraceptive method in Zimbabwe. However, program planners should be aware of this and, as most women in Zimbabwe perceive the FC as highly effective for pregnancy and HIV/STI prevention, continue promotion of the female condom in Zimbabwe for dual purpose. This also may limit the stigma associated with the promotion of female condoms as a disease prophylactic alone. In addition, the majority of women when given the option and proper counseling, choose to use mixed methods. Therefore this promotion can include hormonal and barrier methods as well. Even if female condoms are not the preferred method for the majority of women, they do fill a niche and provide an additional option for women and their partners. With appropriate education, promotion, and availability, the female condom can be a valuable option for pregnancy and STI prevention for Zimbabwean women.
